Epidemiology of diabetic retinopathy and macular oedema: a systematic review (Q34330907)

1 August 2017

1 reference

title

Epidemiology of diabetic retinopathy and macular oedema: a systematic review (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Williams R

1

1 reference

1 August 2017

Airey M

2

1 reference

1 August 2017

Baxter H

3

1 reference

1 August 2017

Forrester J

4

1 reference

1 August 2017

Kennedy-Martin T

5

1 reference

1 August 2017

Girach A

6

1 reference

1 August 2017

1 October 2004

1 reference

1 August 2017

1 reference

1 August 2017

18

1 reference

1 August 2017

963-983

1 reference

1 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701476

1 August 2017

0 references

cites work

Diabetes in the United Kingdom: some facts and figures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

ABC of arterial and venous disease: vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Utility values and diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Influence of a familial history of diabetes on the clinical characteristics of patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy and nephropathy in Fiji: comparison with data from an Australian diabetes centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Epidemiologic study of type 2 diabetes in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Black West Indian and matched white diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Population based assessment of diabetic retinopathy in an urban population in southern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. CODIAB-INSERM-ZENECA Pharma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Visual impairment in type 2 diabetic patients. A multicentre study in France. CODIAB-INSERM-ZENECA Pharma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of retinopathy in a diabetic clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence and risk factors for diabetic retinopathy among Omani diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Pattern of long-term complications in Sudanese insulin-treated diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic complications among American Indians of Washington, Oregon, and Idaho. Prevalence of retinopathy, end-stage renal disease, and amputations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in Mexican Americans and non-Hispanic whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Effects of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic eye complications in a medium sized municipality in southwest Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in people aged 70 years or older. The Oulu Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in pediatric patients with type-1 diabetes: Effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Coronary heart disease and diabetic retinopathy in newly diagnosed diabetes in Da Qing, China: The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Refraction and retinopathy in diabetic children below 16 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The Framingham Eye Study. I. Outline and major prevalence findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Revised Framingham eye study prevalence of glaucoma and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of diabetic retinopathy in children and adolescents with IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Epidemiology of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Photographic detection of retinopathy in insulin-treated diabetes. A population study in the city of Tartu, Estonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Retinopathy in diabetic patients aged 15-50 years in the county of Umeå, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Use of mobile screening unit for diabetic retinopathy in rural and urban areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in a black population: the Barbados Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetes and it's complications in a Swedish county.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Vascular complications in long-term south Indian NIDDM of over 25 years' duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic maculopathy in a Jamaican population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Low vision in Nigerians with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence and pattern of retinal diseases at the Guinness Eye Hospital, Onitsha, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in a population of 1,302 insulin dependent diabetics (IDDM) diagnosed before 30 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of retinopathy at diagnosis among type 2 diabetic patients attending a diabetic centre in South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic eye disease in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The epidemiology and prevalence of diabetic retinopathy in the Veneto region of north east Italy. Veneto Group for Diabetic Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Targets and reality: a comparison of health care indicators in the U.S. (Pittsburgh Epidemiology of Diabetes Complications Study) and Hungary (DiabCare Hungary).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Changing prevalence of retinopathy in newly diagnosed non-insulin dependent diabetes mellitus patients in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

New blindness in diabetes reduced by more than one-third in Stockholm County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

A Population-based Study of the Incidence of Complications Associated with Type 2 Diabetes in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Incidence of blindness due to diabetic eye disease in Fife 1990-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

A prospective, longitudinal study examining the development of retinopathy in children with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prospective study of development of microalbuminuria and retinopathy in Brazilian IDDM patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Blindness due to diabetes: population-based age- and sex-specific incidence rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Development and progression of diabetic retinopathy in Koreans with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Active prevention in diabetic eye disease. A 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Update and implications from the Newcastle diabetic retinopathy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Development and progression of diabetic eye disease in Newcastle (1977-1984): rates and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The 14-year incidence of visual loss in a diabetic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetes in a northern Minnesota Chippewa Tribe. Prevalence and incidence of diabetes and incidence of major complications, 1986-1988.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Development of proliferative retinopathy in Japanese patients with IDDM: Tokyo Women's Medical College Epidemiologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Automated detection of microaneurysms in digital red-free photographs: a diabetic retinopathy screening tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Potential new treatments for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Lowering the risk of visual impairment and blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Mitogen-activated protein kinases as glucose transducers for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

The prevalence of multiple diabetes-related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Coventry Diabetes Study: Prevalence of Diabetes and Impaired Glucose Tolerance in Europids and Asians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

1 reference

7 January 2021

The relation between retinopathy and albumin excretion rate in insulin-dependent diabetes mellitus. From the Funen County Epidemiology of Type 1 Diabetes Complications Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Retinal vascular patterns. IV. Diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The prevalence of retinopathy and associated medical risk factors in type I (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Retinopathy in Pima Indians: Relationships to Glucose Level, Duration of Diabetes, Age at Diagnosis of Diabetes, and Age at Examination in a Population with a High Prevalence of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence and risk factors of retinopathy in children with diabetes. A population-based study on Finnish children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Associations with retinopathy in type 2 diabetes: a population-based study in a Swedish rural area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The prevalence of diabetic retinopathy in northwest Spain. An epidemiological study of diabetic retinopathy in Galicia. I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Clinical and biochemical outcomes of type 2 diabetes mellitus in Canterbury, New Zealand: a 6-year cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Retinopathy in juvenile-onset diabetes of short duration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of retinopathy in diabetic subjects from out-patient clinics in Lombardy (Italy), and associated risk factors. A multicentre epidemiologic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The frequency and severity of retinopathy are related to HbA1c values after, but not at, the diagnosis of NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Ophthalmic findings among one thousand inhabitants of Rarotonga, Cook Islands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetic complications and their relationships to risk factors in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Chronic diabetic complications in patients with MODY3 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of retinopathy in diabetes treated with oral antihyperglycaemic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Retinopathy in young-onset diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of diabetic complications in relation to risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of diabetes mellitus and its complications in the Ukraine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of chronic complications in Japanese diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Alcohol consumption and the prevalence of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Vascular complications in young Asian Indian patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetic retinopathy at the time of diagnosis of NIDDM in south Indian subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetes mellitus in Hopi and Navajo indians. Prevalence of microvascular complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, U.K

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Morbidity in 565 type 2 diabetic patients according to stage of nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The epidemiology of diabetes in Malta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Prevalence of Diabetic Retinopathy: Effect of Sex, Age, Duration of Disease, and Mode of Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Microalbuminuria and retinopathy in a diabetic population of Cameroon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Impact of Late Complications in Type 2 Diabetes in a Dutch Population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

High prevalence of retinopathy among type 2 diabetic patients with no visual complaint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Visual impairment with diabetes: estimates of lower and upper limits of prevalence in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Occurrence of late specific complications in type II (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Increased Prevalence of Proliferative Retinopathy and Cardiovascular Autonomic Dysfunction in IDDM Patients with Proteinuria1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

A 5-year follow-up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetic retinopathy during pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Prevalence and development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. A longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The development and progression of diabetic retinopathy in type I diabetic patients: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

A cohort study of the relationship of diabetic retinopathy to blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Relation of glycemic control to diabetic microvascular complications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Cigarette smoking and ten-year progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Ocular factors in the incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Ten-year incidence of visual loss in a diabetic population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The association of alcohol consumption with the incidence and progression of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

The incidence of vision loss in a diabetic population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Diabetic retinopathy as a cause of blindness in the province of Turin, north-west Italy, in 1967-1991

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701476

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701476

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference